Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0001193125-25-337051

Chief Financial Officer sold 77,000 shares at $38.68 ($2,978,360)

From the SEC's structured data for this filing

Trades in this filing

Green John L. · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-12-26 Sale : show line 1 in the form −77,000 $38.68 $2,978,360 131,834 D
Open-market sales · 77,000 sh · avg $38.68 · $2,978,360
Loading xslF345X05/ownership.xml…